
Polar Electro OY
Polar Electro OY
9 Projects, page 1 of 2
Open Access Mandate for Publications and Research data assignment_turned_in Project2020 - 2023Partners:AMIRES THE BUSINESS INNOVATION MANAGEMENT INSTITUTE ZU, PCAS (France), SOLAR POWER FILMS GMBH, TNO, NTUA +10 partnersAMIRES THE BUSINESS INNOVATION MANAGEMENT INSTITUTE ZU,PCAS (France),SOLAR POWER FILMS GMBH,TNO,NTUA,UOXF,Imperial,CUT,Polar Electro OY,ASCA,Plastic Logic (United Kingdom),P.V. NANO CELL LTD,AMIRES SRO,AVANTAMA AG,FLEXENABLE TECHNOLOGY LIMITEDFunder: European Commission Project Code: 862474Overall Budget: 5,762,740 EURFunder Contribution: 4,705,040 EURRoLA–FLEX is an industry driven project which provides innovative solutions to the existing OLAE challenges associated with performance and lifetime, through: (a) the fabrication and upscaling of organic semiconductors with high charge mobilities (up to 10 cm2/Vs) and high power conversion efficiencies (16% in OPV cell and 12% in OPV module); (b) the development of metal oxides for charge carrier selective contacts and metal nanoinks for highly conductive micropatterns with increased environmental stability; (c) the seamless incorporation of high speed laser digital processing in Roll-2-Roll OPV module fabrication and photolithography based OTFT manufacturing and (d) the demonstration of two TRL5+ OLAE prototypes enabled by the developed materials and innovative processes: 1. A smart energy platform for IoT devices powered by ITO-free and flexible OPVs operating at low indoor light conditions. 2. A new generation of bezel-less and fully bendable smart watches integrating FHD, ultra-bright OLCD/OTFT displays. RoLA-FLEX will advance all the aforementioned technologies to at least TRL5 within its timeframe. RoLA-FLEX will create an opportunity for a yearly increase in revenues of almost €400 M only 6 years after its end, accompanied by hundreds of new jobs. A timely investment in the early days of these new markets can ensure significant market share for the SMEs and Industries involved and greatly boost EU’s competitiveness globally.
more_vert Open Access Mandate for Publications and Research data assignment_turned_in Project2024 - 2028Partners:AMIRES SRO, GRAPHENEA SEMICONDUCTOR SL, TEKNOLOGIAN TUTKIMUSKESKUS VTT OY, JSI, OYKS +5 partnersAMIRES SRO,GRAPHENEA SEMICONDUCTOR SL,TEKNOLOGIAN TUTKIMUSKESKUS VTT OY,JSI,OYKS,XTPL,Polar Electro OY,BETTHERA,UPV,NTUAFunder: European Commission Project Code: 101130192Funder Contribution: 6,984,470 EURThe prevalence of overweight among the European population is estimated to be near 50% and the prevalence of obesity around 16%. Monitoring obesity and overweight prevalence is important for assessing interventions aimed at preventing or reducing the burden of obesity and related medical risks and providing the tools for maintaining a healthier lifestyle. UltraSense project introduces the concept of a stretchable multi-sensing platform, as a wearable tool for body composition analysis and overall decentral health monitoring, fostering a sustainable and healthier lifestyle. The platform will comprise smart features, AI signal processing and advanced stretchable materials, enabling the efficient synergy of three compartments of sensors relying on different technologies: A. Ultra-sound compartment: delivering precise information about body composition and tissue thickness B. Bioimpedance compartment: fast and reliable measuring of the percentage of fat, water and muscle C. G-FET biosensor compartment: Biomarker retrieval via sweating at atto-Molar sensitivity in miniaturized footprint The wearable device will be validate in two use cases: 1. The effect of sport on a healthier lifestyle: monitoring the overall health of people who exercise 2. Early detection and continuous monitoring of metabolic syndrome. Ultra-Sense's data will be displayed to the user with consistency and reliability, so that medical advice can be sought. The green and circular material synthesis approaches of the project will reduce the related CO2 emissions by more than 70% from solvent processing. UltraSense will have a huge societal and economic impact: 700k devices will be sold annually already by 2032 for 105M€ of revenues reaching a 10% market share and associated with 20 new jobs. Millions of people will have access to low-cost, easy to use device informing of their body composition helping them improve their lifestyle, reducing obesity and metabolic diseases, and related treatment costs.
more_vert Open Access Mandate for Publications assignment_turned_in Project2019 - 2022Partners:Varta Microbattery (Germany), Beiersdorf (Germany), TEKNOLOGIAN TUTKIMUSKESKUS VTT OY, CEA, IMEC +4 partnersVarta Microbattery (Germany),Beiersdorf (Germany),TEKNOLOGIAN TUTKIMUSKESKUS VTT OY,CEA,IMEC,D. Swarovski Distribution GmbH,D. SWAROVSKI KG,Polar Electro OY,Stuttgart Media UniversityFunder: European Commission Project Code: 825172Overall Budget: 4,164,840 EURFunder Contribution: 4,164,840 EURBEWELL project is about developing integration and manufacturing technologies needed for smart skin patch and wrist-device wearable electronics sensing and actuating products. BEWELL project is also about demonstrating three different application use cases. Wearable electronics belongs to new age consumer electronics together with smartphones, gaming consoles and laptop/tablet computers. Key development focuses of the new devices are better human-machine interfaces, improved connectivity, user-friendly form factors and convenience of use. Internet of things, connected living, quantified self and smart homes are identified as the driving trends of this evolution among which especially the quantified self is clearly driving the wearable electronics. Inside wearable electronics, wrist-worn devices have been the largest segment but body-worn and head-worn devices are expected to grow to similar sized segments. Intimate skin contact is necessary for reliable sensing and actuation based on sensor results during different levels of activity of the users. Controllable skin contact would be a further improvement in sensing applications. The purpose can be to replace or supplement visual messaging. Therefore, skin patches and associated technologies to enhance the user-device interface also in other types of products such as the wrist-worn ones are of special importance. In BEWELL, we have identified commercially relevant future skin-patch products to be demonstrated. We have also identified a set of critical and versatile technologies that need to be developed for scalable manufacturing and integrated to realize these future products. In particular, the BEWELL project aims to unleash the potential of flexible and wearable electronics for physical and emotional wellbeing by advanced integrated technology components made in Europe.
more_vert Open Access Mandate for Publications and Research data assignment_turned_in Project2025 - 2027Partners:SDU, Polar Electro OY, CNRS, TEKNOLOGIAN TUTKIMUSKESKUS VTT OY, INNOCELL APS +3 partnersSDU,Polar Electro OY,CNRS,TEKNOLOGIAN TUTKIMUSKESKUS VTT OY,INNOCELL APS,DRACULA TECHNOLOGIES,CARDLAB INNOVATION APS,E-PEASFunder: European Commission Project Code: 101172820Funder Contribution: 2,972,690 EURThe project Efficient Organic Photovoltaic Sensors (EFFECTOR) will deliver innovative and environmentally-friendly solutions for digital and wearable electronics at TRL7. These objects will be individually powered by harvesting low-level light and will be made from sustainable materials for a bright digital future. EFFECTOR will contribute to a strategic position through an open economy in the key digital, and human-centric emerging technology by developing highly sustainable energy harvesting under diffuse, low-light conditions in the key areas of security and health. EFFECTOR will create new sustainable European value chains for photovoltaic technologies and open new innovative business-to-business operations by doubling the efficiency of non-toxic organic solar cells for use under low-level light. It will couple in a streamline way with non-toxic, sustainable supercapacitors with advanced low power electronics. The EFFECTOR strategy is to bring solar cell technology to mainstream use by eliminating the need for mains electricity from everyday human-centred electronics. It will develop sustainable materials and processes, using non-toxic materials and reducing environmental impact applicable for a huge raft of human-centred technologies and innovations. EFFECTOR draws on the world-leading inkjet OPV manufacturing of Dracula Technologies, the sustainable non-toxic aqueous supercapacitors of Innocell, and the high fidelity power management systems from e-peas. With its world-leading academic partners in solar cell design (SDU), high throughput industrial electronic printing and integration (VTT) and polymers for solar cell stabilization (CNRS), it will demonstrate this innovative multi-faceted approach in vital health monitoring with Polar and portable device applications with CardLab’s biometric card technology. EFFECTOR will demonstrate how low-level and indoor light can power our future in a secure, reliable and sustainable way.
more_vert Open Access Mandate for Publications and Research data assignment_turned_in Project2024 - 2027Partners:SANMINA IRELAND UNLIMITED COMPANY, IPHT, MACULASER OY, UCC, Polar Electro OY +32 partnersSANMINA IRELAND UNLIMITED COMPANY,IPHT,MACULASER OY,UCC,Polar Electro OY,III V Lab,CUROLED GMBH,FICONTEC SERVICE GMBH,CY.R.I.C CYPRUS RESEARCH AND INNOVATION CENTER LTD,GASERA,microTEC,FINNADVANCE OY,TAMPERE UNIVERSITY,SURFIX BV,SCINVIVO B.V.,LABQUALITY OY,WISEMATIC OY,TEKNOLOGIAN TUTKIMUSKESKUS VTT OY,VOXDALE,MANTISPECTRA B.V.,BIONAVIS OY,Scienion (Germany),PHILIPS ELECTRONICS NEDERLAND B.V.,Kaminari Medical,TNO,AMO GMBH,QURIN DIAGNOSTICS B.V.,IMEC,MEEP,FICONTEC IRELAND LIMITED,University of Freiburg,UM,LGT-FR,Etteplan,ERASMUS MC,BIALOOM LTD,LGFunder: European Commission Project Code: 101139777Overall Budget: 32,445,200 EURFunder Contribution: 10,894,200 EURPhotonics is a key enabling technology in the realization of modern medical devices with applications ranging from diagnostics to personalised monitoring and therapeutics. Characteristic nature of both photonics and medical applications is high diversity. Therefore, the more widespread use of photonics technologies in scattered ecosystems presents major challenges for the technological values chains comprising end-user companies and manufacturers. In conjunction with highly regulated validation and production processes, the timespan from the proof-of-concept to product launch takes years causing high costs. Relying on existing pilot line concept, PhotonMed aims at accelerated uptake of the latest photonics technologies in medical device applications. PhotonMed project is applied to continuously renew the technology offering of photonics pilot line and to invite new members and countries to join the ecosystem. Within research-oriented PhotonMed project RTOs and industrial parties can develop their technology offering while the end-user companies get matured demonstrators based on the latest research results.
more_vert
chevron_left - 1
- 2
chevron_right